Organicell Regenerative Medicine
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Organicell Regenerative Medicine's past years’ income statements indicate that its last revenue has increased compared to the previous period by 80% to $3,055,776. Profit margin reached -412%. Total operating expenses were $15,095,111.

Profit Margin

Organicell Regenerative Medicine, Inc. (OTC:BPSR): Profit margin
2012 87.14K -12.33K -14.16%
2013 82.96K -32.17K -38.78%
2014 49.19K -65.81K -133.78%
2015 147.62K -738.35K -500.14%
2016 184.88K -1.25M -677.84%
2017 569.84K -8.97M -1574.49%
2018 964.53K -3.46M -358.95%
2019 1.70M -1.73M -102.06%
2020 3.05M -12.58M -411.78%

BPSR Income Statement (2012 – 2020)

2020 2019 2018 2017 2016 2015 2014 2013 2012
Revenue
Revenue
3.05M1.70M964.53K569.84K184.88K147.62K49.19K82.96K87.14K
Cost of revenue
398.60K300.83K209.29K160.62K94.40K49.41K20.05K44.44K61.11K
Gross profit
2.65M1.40M755.23K409.21K90.47K98.21K29.13K38.52K26.03K
Operating exp.
Research and development
000000000
Selling and marketing
000000000
Total operating expenses
15.09M3.17M4.24M9.05M1.13M861.09K94.95K70.70K38.37K
Operating income
-12.43M-1.77M-3.49M-8.64M-1.04M-762.88K-65.81K-32.17K-12.33K
Other income (expenses), net
-145.02K38.19K58.69K-470.99K-12.72K0000
Income before tax
-12.58M-1.73M-3.43M-9.11M-1.05M-762.88K-65.81K-32.17K-12.33K
Income tax expense
32.71K84.79K287.02K105.02K00000
Net income
-12.58M-1.73M-3.46M-8.97M-1.25M-738.35K-65.81K-32.17K-12.33K
Earnings per share
Basic EPS
-0.01-0.00-0.01-0.08-0.01-0.00-0.00-0.00-0.00
Diluted EPS
-0.01-0.00-0.01-0.08-0.01-0.00-0.00-0.00-0.00
Data sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData source